Aplastic anaemia is a rare, life‐threatening disorder of the bone marrow characterised by pancytopenia and a hypocellular marrow. The primary pathophysiology involves immune-mediated destruction of ...

Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

GRAND RAPIDS, Mich. — At just 18 years old, Lilly VandenBosch has already faced a lifetime of challenges. Diagnosed with aplastic anemia, a rare blood disorder, at the age of 7, her journey has been ...

Severe aplastic anemia is a rare bone marrow disease which is characterized by insufficient red blood cell production. This life-threatening disease typically occurs with two peaks around 25 and 60 ...

The European Society for Blood and Marrow Transplantation (EBMT), Europe's collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced ...

The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with severe aplastic anemia (SAA). New research ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.

On the surface, Owen Ho looked fine. But on the inside, it was a different story. Ho, 42, was exhausted. He couldn’t muster up the strength to exercise even though months earlier, six-hour bike rides ...

Stephanie Matto suffers from a rare and life-threatening disease. Pic credit: @stepankamatto/Instagram. Stephanie Matto has one of the most interesting storylines on ...